BiologySeptember 15, 2016
A Scientific Crisis That Starts in the Market, Not the Lab
Only 50 percent of the antibodies produced commercially for biomedical research actually do what they’re supposed to
Stories by Jason Li
Jason Li, Ph.D. (jasonl@ptglab.com), is CEO of Proteintech Group, Inc. He is addressing the International Antibody Validation Meeting in Bath, U.K., in September of 2016 on the importance of transparency in the antibody industry.